JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹195 Cr | ₹164 Cr | ₹141 Cr | ₹143 Cr | ₹120 Cr |
What is the latest Total Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹195 Cr |
| Mar2024 | ₹164 Cr |
| Mar2023 | ₹141 Cr |
| Mar2022 | ₹143 Cr |
| Mar2021 | ₹120 Cr |
How is Total Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹195 Cr | 18.51 | |
| Mar2024 | ₹164 Cr | 16.21 | |
| Mar2023 | ₹141 Cr | -0.84 | |
| Mar2022 | ₹143 Cr | 18.38 | |
| Mar2021 | ₹120 Cr | - | |
Compare Total Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹468.1 Cr | 1% | -5.4% | -5.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 5.7% | -3.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.6% | -7.6% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -0.5% | 0.9% | 23.6% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 0.5% | -12.9% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5.3% | -0.9% | 1.9% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 1% |
-5.4% |
-5.3% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses